Skip to main content
logo
Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
4.160
+0.040 (0.97%)
At close: Oct 28, 2025, 4:00 PM EDT
4.130
-0.030 (-0.72%)
After-hours: Oct 28, 2025, 4:00 PM EDT

Evotec SE Revenue

Evotec SE had revenue of 171.24M EUR in the quarter ending June 30, 2025, a decrease of -5.98%. This brings the company's revenue in the last twelve months to 777.33M, down -1.41% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.

Revenue (ttm)
777.33M EUR
Revenue Growth
-1.41%
P/S Ratio
1.60
Revenue / Employee
163,994 EUR
Employees
4,740
Market Cap
1.46B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024796.97M15.54M1.99%
Dec 31, 2023781.43M29.98M3.99%
Dec 31, 2022751.45M133.41M21.59%
Dec 31, 2021618.03M117.11M23.38%
Dec 31, 2020500.92M54.49M12.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG56.37B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings

EVO News

More News